Sign in

CIK 0001681087

  • Non-accelerated filer
  • Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
810710585
Phone
+1 339-666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Chief Medical Officer sold 1,065 shares at $30.00 ($31,950)
  4. 4 Planned sale Chief Medical Officer sold 1,000 shares at $31.05 ($31,050)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Planned sale Chief Medical Officer sold 10,000 shares at $30.00 ($300,000)
  8. 4 Planned sale Chief Scientific Officer sold 6,262 shares at an average $30.17 ($188,935)
  9. 4 Grant or award Chief Executive Officer acquired 76,500 shares (grant or award)
  10. 4 Grant or award Chief Business Officer acquired 19,500 shares (grant or award)
  11. 4 Planned sale Chief Scientific Officer sold 3,299 shares at an average $23.53 ($77,627)
  12. 4 Grant or award Chief Financial Officer acquired 26,500 shares (grant or award)
  13. 4 Grant or award Chief Medical Officer acquired 26,500 shares (grant or award)
  14. 4/A Open-market buy Chief Executive Officer bought 2,500 shares at $21.10 ($52,750)
  15. 4 Open-market buy Chief Executive Officer bought 2,500 shares at $21.10 ($52,750)
  16. 4 Exercise or conversion Chief Business Officer acquired 4,500 shares (option exercise)
  17. 4 Open-market buy Chief Financial Officer bought 6,000 shares at $21.61 ($129,660)
  18. 4 Shares withheld for taxes Chief Business Officer gave up 1,619 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Medical Officer gave up 2,064 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 4,104 shares (to pay taxes)

Page 2 of 12 · 226 filings